Anthera Pharmaceuticals (ANTH) gains despite Q1 loss

May 12, 2015 11:46 AM | 13 seconds read |
Anthera Pharmaceuticals Inc ANTH shares climbed 4.5% to $4.68. Anthera Pharmaceuticals reported a Q1 loss of $0.28 per share. Citigroup upgraded Anthera Pharmaceuticals from sell to neutral. Share volume was 134,000, compared to an all-day average of 236,000
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!